Blogs

AbbVie will present a total of 23 abstracts across several tumor types including brain cancer, hematologic malignancies, breast cancer, lung cancer and other solid tumors. Researchers will present efficacy and safety data on depatuxizumab mafodotin, an antibody-drug conjugate (ADC) being studied for the treatment of adults with amplified EGFR newly Continue Reading
 Categories : ASCO17, Oncology Posted by Nirmala Vittaladevuni  ,
Liquid Biopsy is a term given to a minimally invasive method of analyzing Tumor cell DNA circulating in the blood. This is a useful and very promising approach and opens new vistas compared to the Biochemical Biomarkers and Tissue Biopsies dependent monitoring of cancer. However, it throws its own challenges Continue Reading
 Categories : ASCO17, ASCO18, Oncology Posted by Rajeev Kumria  , ,
At ASCO 2017, the steadily increasing competitive intensity between Lonsurf (TAS-102, Taiho) and Stivarga (regorafenib, Bayer) will be on display . In addition, the I/O agents are reading out both as monotherapy in specific (dMMR/MSI-H) patient segments, as well as in combinations with other cytotoxic and targeted agents in broader patient Continue Reading
 Categories : ASCO17, Oncology Posted by Preeti Parikh  ,
ASCO 2017 is primarily setting the stage for future as it relates to Prostate Cancer – a large number of presentations are focused on early stage data from new compounds and/or combinations of existing. The truly practice impacting trials such as IMbassador250, ARASENS, PROfound and TRITON3 will be touched upon Continue Reading
 Categories : ASCO17, Oncology Posted by Zahid Nabi  ,
Colorectal Cancer Diagnostics and monitoring CRC diagnostics and monitoring follows two pronged strategy Diagnostic tools such as Colonoscopy: Specific, Can Remove Polyps and Take Biopsies. Adverse: Can cause perforation, Can miss small adenomas Flexible sigmoidoscopy: Specific, Can Remove Polyps and Take Biopsies. Adverse: Reduced risk of perforation Double-contrast barium enema: Continue Reading
 Categories : ASCO17, ASCO18, Biomarker, Oncology Posted by Rajeev Kumria  , ,
Digital Health revolution is around the corner and it won’t be long when this technology will start affecting our daily life and the way we consume healthcare products and services. The divide however is still a long one and from a consumer standpoint, there is a lack of understanding of Continue Reading
 Categories : Digital Health Posted by Rajeev Kumria